Atypical chronic myeloid leukemia with concomitant CSF3R T618I and SETBP1 mutations unresponsive to the JAK inhibitor ruxolitinib
Crossref DOI link: https://doi.org/10.1007/s00277-014-2272-0
Published Online: 2014-12-11
Published Print: 2015-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ammatuna, Emanuele
Eefting, Matthias
van Lom, Kirsten
Kavelaars, François F.
Valk, Peter J. M.
Touw, Ivo P.
Text and Data Mining valid from 2014-12-11